.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Evolving Strategies for Advanced Colon and Rectal Cancers

EP. 1: EGFR Therapy for Right-Sided CRC

February 14th 2019

EP. 2: Recommendations for Molecular Testing in mCRC

February 14th 2019

EP. 3: EGFR Therapy in Left-Sided CRC

February 14th 2019

EP. 4: Maintenance Strategies for Patients With mCRC

February 14th 2019

EP. 5: Sequencing Therapy in CRC: E7208 Trial

February 14th 2019

EP. 6: Sequencing Therapy in CRC: REVERCE Trial

February 14th 2019

EP. 7: Triplet Regimens for BRAF V600E-Positive mCRC

February 14th 2019

EP. 8: Management of NTRK Fusions in CRC

February 14th 2019

EP. 9: Rationale for I-O in mCRC

February 14th 2019

EP. 10: Treatment Recommendations for Relapsed/Refractory mCRC

February 14th 2019

EP. 11: Relapsed/Refractory mCRC: Treatment Dosing Strategies

February 14th 2019

EP. 12: Adjuvant Therapy for Early-Stage Colon Cancer

February 14th 2019

EP. 13: Patient Stratification in Colon Cancer: ctDNA

February 14th 2019

EP. 14: Adjuvant Therapy for High-Risk Colon Cancer

February 14th 2019

EP. 15: Neoadjuvant Strategies for Rectal Cancer

February 14th 2019

EP. 16: Improving Care for Patients With Colon/Rectal Cancer

February 14th 2019